Topics
Gliomas | Treatment | Side-effects | Temozolomide
Home > Publications > Topics > Gliomas > Treatment > Side-effects > Temozolomide
Wei
S, Chang L, Zhong Y.
The
efficacy and adverse events of bevacizumab combined with
temozolomide in the treatment of glioma: a systemic review and
meta-analysis of randomized controlled trials.
Front
Med (Lausanne).
2024 Jul 2;11:1419038. doi:
10.3389/fmed.2024.1419038. PMID:
39015784. Review; Meta-analysis. ˍ
Zhou Y, Jia P, Fang Y, Zhu W, Gong Y, Fan T, Yin J.
Comprehensive
understanding of the adverse effects associated with temozolomide:
a disproportionate analysis based on the FAERS database.
Front
Pharmacol. 2024 Aug 23;15:1437436. doi:
10.3389/fphar.2024.1437436. PMID:
39246656. Observational study. ˍ
Hiong A, Lapidus AH, Gately L, Sinclair G, Ameratunga M.
Herpes
zoster in patients with glioma treated with temozolomide.
J
Clin Neurosci. 2024 Sep 1;129:110816. doi:
10.1016/j.jocn.2024.110816? PMID:
39222582. Observational study˰
ˍ
Wang C, Duan L, Zhao Y, Wang Y, Li Y.
Efficacy
and safety of bevacizumab combined with temozolomide in the
treatment of glioma a systematic review and meta-analysis of
clinical trials.
World Neurosurg. 2024 Oct
24:S1878-8750(24)01775-3? doi:
10.1016/j.wneu.2024.10.071? PMID:
39461419. Review; Meta-analysis˰
ˍ